182 related articles for article (PubMed ID: 23729200)
1. Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy.
Wittwer C; Boeck S; Heinemann V; Haas M; Stieber P; Nagel D; Holdenrieder S
Int J Cancer; 2013 Dec; 133(11):2619-30. PubMed ID: 23729200
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients.
Fahmueller YN; Nagel D; Hoffmann RT; Tatsch K; Jakobs T; Stieber P; Holdenrieder S
Int J Cancer; 2013 May; 132(10):2349-58. PubMed ID: 23047645
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.
Kohles N; Nagel D; Jüngst D; Stieber P; Holdenrieder S
Tumour Biol; 2012 Dec; 33(6):2401-9. PubMed ID: 22965881
[TBL] [Abstract][Full Text] [Related]
4. Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy.
Stoetzer OJ; Wittwer C; Lehner J; Fahmueller YN; Kohles N; Fersching DM; Leszinski G; Roessner J; Holdenrieder S
Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S217-24. PubMed ID: 22620489
[TBL] [Abstract][Full Text] [Related]
5. Functional role of soluble receptor for advanced glycation end products in stroke.
Tang SC; Wang YC; Li YI; Lin HC; Manzanero S; Hsieh YH; Phipps S; Hu CJ; Chiou HY; Huang YS; Yang WS; Mattson MP; Arumugam TV; Jeng JS
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):585-94. PubMed ID: 23288172
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
Clin Biochem; 2011 Jun; 44(8-9):601-4. PubMed ID: 21211520
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis.
Kocsis AK; Szabolcs A; Hofner P; Takács T; Farkas G; Boda K; Mándi Y
Pancreatology; 2009; 9(4):383-91. PubMed ID: 19451748
[TBL] [Abstract][Full Text] [Related]
9. Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy.
Stoetzer OJ; Fersching DM; Salat C; Steinkohl O; Gabka CJ; Hamann U; Braun M; Feller AM; Heinemann V; Siegele B; Nagel D; Holdenrieder S
Tumour Biol; 2013 Feb; 34(1):81-90. PubMed ID: 22983919
[TBL] [Abstract][Full Text] [Related]
10. Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality.
Cheng Y; Zhong J; Xiang Y; Zeng F; Cai D; Zhao L
Clin Interv Aging; 2014; 9():1981-6. PubMed ID: 25429209
[TBL] [Abstract][Full Text] [Related]
11. Relevance of Circulating Nucleosomes, HMGB1 and sRAGE for Prostate Cancer Diagnosis.
Garrido MM; Ribeiro RM; Krüger K; Pinheiro LC; Guimarães JT; Holdenrieder S
In Vivo; 2021; 35(4):2207-2212. PubMed ID: 34182498
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels of a soluble form of receptor for advanced glycation end products and high-mobility group box chromosomal protein 1 in patients with acute pancreatitis.
Lindström O; Tukiainen E; Kylänpää L; Mentula P; Rouhiainen A; Puolakkainen P; Rauvala H; Repo H
Pancreas; 2009 Nov; 38(8):e215-20. PubMed ID: 19786934
[TBL] [Abstract][Full Text] [Related]
13. Soluble Forms and Ligands of the Receptor for Advanced Glycation End-Products in Patients with Acute Respiratory Distress Syndrome: An Observational Prospective Study.
Jabaudon M; Blondonnet R; Roszyk L; Pereira B; Guérin R; Perbet S; Cayot S; Bouvier D; Blanchon L; Sapin V; Constantin JM
PLoS One; 2015; 10(8):e0135857. PubMed ID: 26274928
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of high-mobility group box 1 and soluble receptor for advanced glycation end products in primary antiphospholipid antibody syndrome patients.
Tang KT; Hsieh TY; Chao YH; Lin MX; Chen YH; Chen DY; Lin CC
PLoS One; 2017; 12(5):e0178404. PubMed ID: 28558055
[TBL] [Abstract][Full Text] [Related]
15. Circulating soluble RAGE increase after a cerebrovascular event.
Menini T; Ikeda H; Kimura S; Gugliucci A
Clin Chem Lab Med; 2014 Jan; 52(1):109-16. PubMed ID: 23492566
[TBL] [Abstract][Full Text] [Related]
16. Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Suzuki T; Yamada S; Takeuchi M; Fukami K; Ueda S; Adachi H; Matsui T; Okuda S; Yamagishi S
Metabolism; 2009 Nov; 58(11):1624-8. PubMed ID: 19604520
[TBL] [Abstract][Full Text] [Related]
17. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury.
Craig DG; Lee P; Pryde EA; Masterton GS; Hayes PC; Simpson KJ
Liver Int; 2011 Sep; 31(8):1127-36. PubMed ID: 21745283
[TBL] [Abstract][Full Text] [Related]
18. [The Value of Serum HMGB1 and sRAGE in the Diagnosis, Efficacy Monitoring and Prognosis of Newly Diagnosed Multiple Myeloma].
Wang J; Zeng AM; Liang SF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):493-500. PubMed ID: 35395985
[TBL] [Abstract][Full Text] [Related]
19. High-mobility group box-1 (HMGB-1) and serum soluble receptor for advanced glycation end products (sRAGE) in children affected by vernal keratoconjunctivitis.
Zicari AM; Zicari A; Nebbioso M; Mari E; Celani C; Lollobrigida V; Cesoni Marcelli A; Occasi F; Duse M
Pediatr Allergy Immunol; 2014 Feb; 25(1):57-63. PubMed ID: 24236762
[TBL] [Abstract][Full Text] [Related]
20. Soluble receptor of advanced glycation end products (sRAGE) indicates response to chemotherapy in pancreatic cancer patients.
Wittwer C; Boeck S; Heinemann V; Haas M; Stieber P; Nagel D; Holdenrieder S
Int J Clin Pharmacol Ther; 2013 Jan; 51(1):67-9. PubMed ID: 23260004
[No Abstract] [Full Text] [Related]
[Next] [New Search]
